Skip to main content

Rifabutin Capsules, USP 150mg (Novitium Pharma, USA)

Section 19A approved medicine
Rifabutin Capsules, USP 150mg (Novitium Pharma, USA)
Section 19A approval holder
ORSPEC Pharma Pty Ltd​ ABN 15 634 980 417
Phone
02 4339 4239
Approved until
Status
Current
Medicines in short supply/unavailable
MYCOBUTIN Rifabutin 150mg capsule blister pack - ARTG 55038
Indication(s)

The prophylaxis of M. avium-intracellulare complex (MAC) infections in patients with advanced HIV infection (CD4 counts lower than 200/uL).

Images
Picture of Rifabutin Capsules USP 150mg - label